Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

firstwordpharma.com
firstwordpharma.com > story > 7983565

AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial

6+ hour, 39+ min ago   (12+ words) firstwordpharma.com...

firstwordpharma.com
firstwordpharma.com > story > 7973027

Friday Five??? Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal???and more

2+ day, 12+ hour ago   (19+ words) Friday Five – Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal…and more firstwordpharma.com...

firstwordpharma.com
firstwordpharma.com > story > 7972707

Vital Signs: Tracking the trials and tribulations ahead for CVOTs

2+ day, 15+ hour ago   (11+ words) firstwordpharma.com...

FirstWord PHARMA
firstwordpharma.com > story > 7972962

AbbVie aims to expand Qulipta's label into new migraine market

2+ day, 13+ hour ago   (12+ words) FirstWord PHARMA...

FirstWord PHARMA
firstwordpharma.com > story > 7972418

Animal data trigger enrollment pause in Biohaven's epilepsy study

2+ day, 17+ hour ago   (11+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7969518

NodThera rebrands as Rezera, charts registrational path for PAD drug

3+ day, 6+ hour ago   (12+ words) FirstWord Pharma...

firstwordpharma.com
firstwordpharma.com > story > 7969456

Spotlight On: What to watch at World Lung 2026

3+ day, 7+ hour ago   (10+ words) firstwordpharma.com...

FirstWord PHARMA
firstwordpharma.com > story > 7968650

Encoded pulls in $275M for pivotal study of Dravet gene therapy

3+ day, 13+ hour ago   (13+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7966708

Physician Views Results: Neurologists express cautious optimism for BTK inhibitors in MS

4+ day, 3+ min ago   (14+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7967524

TwoStep's take on targeting solid tumours gains backing from Merck KGaA, Pfizer venture arms

3+ day, 20+ hour ago   (16+ words) FirstWord Pharma...